SPPI
Price:
$1.025
Market Cap:
$210.38M
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license...[Read more]
Industry
Biotechnology
IPO Date
1996-09-26
Stock Exchange
NASDAQ
Ticker
SPPI
According to Spectrum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Spectrum Pharmaceuticals, Inc. over the last ten years is 3.90%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), SPPI's Dividend Yield was at its highest in in the December 2013 quarter at 19.31%. The Dividend Yield was at its lowest in in the June 2013 quarter at 0%.
Average
3.90%
Median
0%
Minimum
0%
Maximum
38.59%
Discovering the peaks and valleys of Spectrum Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 38.59%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | -100.00% |
2017 | 0.40% | 21.52% |
2016 | 0.00% | Infinity% |
2015 | 0% | 0% |
2014 | 0% | -100.00% |
2013 | 38.59% | 2.71% |
The current Dividend Yield of Spectrum Pharmaceuticals, Inc. (SPPI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
3.90%
Spectrum Pharmaceuticals, Inc.’s Dividend Yield is less than Selecta Biosciences, Inc. (0%), less than Paratek Pharmaceuticals, Inc. (0%), less than Corvus Pharmaceuticals, Inc. (0%), less than Immutep Limited (0%), less than Icosavax, Inc. (0%), less than Ardelyx, Inc. (0%), less than Zura Bio Limited (0%), less than Hepion Pharmaceuticals, Inc. (0%), less than AVROBIO, Inc. (0%), less than Verastem, Inc. (0%), less than Agios Pharmaceuticals, Inc. (0%), less than bluebird bio, Inc. (0%), less than Intercept Pharmaceuticals, Inc. (0%), less than Karyopharm Therapeutics Inc. (0%), less than BioLineRx Ltd. (0%), less than Lexicon Pharmaceuticals, Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than ImmunityBio, Inc. (0%), less than Gamida Cell Ltd. (0%), less than Rigel Pharmaceuticals, Inc. (0%), less than Geron Corporation (0%), less than ImmunoGen, Inc. (0%), less than null (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $135.20M | |
0% | $127.83M | |
0% | $252.08M | |
0% | $382.21M | |
0% | $769.04M | |
0% | $1.32B | |
0% | $230.86M | |
0% | $4.20M | |
0% | $5.24M | |
0% | $96.58M | |
0% | $2.46B | |
0% | $101.94M | |
0% | $794.69M | |
0% | $91.04M | |
0% | $55.61M | |
0% | $582.00M | |
0% | $145.36M | |
0% | $2.35B | |
0% | $4.34M | |
0% | $234.37M | |
0% | $2.56B | |
0% | $8.73B | |
0% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spectrum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spectrum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Spectrum Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Spectrum Pharmaceuticals, Inc. (SPPI)?
What is the highest Dividend Yield for Spectrum Pharmaceuticals, Inc. (SPPI)?
What is the 3-year average Dividend Yield for Spectrum Pharmaceuticals, Inc. (SPPI)?
What is the 5-year average Dividend Yield for Spectrum Pharmaceuticals, Inc. (SPPI)?
How does the current Dividend Yield for Spectrum Pharmaceuticals, Inc. (SPPI) compare to its historical average?